Haleon (LON:HLN) Shares Up 0.1% - What's Next?

Key Points

• Haleon shares rose 0.1% to GBX 337.60, while trading volume surged to approximately 2.147 billion shares—more than 54 times the average session volume.
• Analyst views remain mixed, with two Buy, one Hold and two Sell ratings. The consensus rating is Hold, with an average price target of GBX 387.80.
• Haleon reported quarterly EPS of GBX 8.60, a 14.55% net margin and 9.89% return on equity; analysts expect full-year EPS of about 19.50 pence.

Haleon plc (LON:HLN - Get Free Report)'s share price shot up 0.1% on Wednesday. The company traded as high as GBX 341.70 and last traded at GBX 337.60. Approximately 2,147,000,000 shares were traded during mid-day trading, an increase of 5,457% from the average session volume of 38,634,129 shares. The stock had previously closed at GBX 337.10.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Haleon from GBX 335 to GBX 320 and set a "sell" rating for the company in a research report on Wednesday, September 9th. Berenberg Bank raised their price target on shares of Haleon from GBX 512 to GBX 514 and gave the company a "buy" rating in a research report on Wednesday, August 5th. JPMorgan Chase & Co. cut their price target on Haleon from GBX 335 to GBX 315 and set an "underweight" rating for the company in a research note on Thursday, June 25th. Jefferies Financial Group reissued a "buy" rating and set a GBX 400 price objective on shares of Haleon in a report on Friday, July 31st. Finally, Royal Bank Of Canada increased their price objective on Haleon from GBX 370 to GBX 390 and gave the stock a "sector perform" rating in a research note on Tuesday, August 11th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of GBX 387.80.

Haleon Stock Up 0.1%

The company has a current ratio of 0.69, a quick ratio of 0.93 and a debt-to-equity ratio of 50.38. The stock has a market capitalization of £29.69 billion, a PE ratio of 18.65, a P/E/G ratio of 1.49 and a beta of 0.24. The stock's fifty day simple moving average is GBX 355.91 and its 200-day simple moving average is GBX 353.07.

Haleon (LON:HLN - Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported GBX 8.60 EPS for the quarter. Haleon had a net margin of 14.55% and a return on equity of 9.89%. As a group, sell-side analysts forecast that Haleon plc will post 19.5033282 EPS for the current fiscal year.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.